Graphical Abstract Highlights d Monoclonal antibody FVM04 blocks interaction of ebolavirus with its host receptor d FVM04 cross-neutralizes and protects against EBOV and SUDV in rodents d A new ZMapp version that includes FVM04 protects guinea pigs from EBOV and SUDV d Specific GP mutations expose epitopes for FVM04 and other cross-neutralizing mAbs 